search button

Association of the interleukin‑18 ‑137 C/G, ‑607 A/C polymorphisms with type 1 diabetes: A meta‑analysis

  • Authors:
    • Jing Li
    • Song Wu
    • Ming‑Rui Wang
    • Ting‑Ting Wang
    • Bai‑Kun Li
    • Ji‑Min Zhu

  • View Affiliations

  • Published online on: October 23, 2013     https://doi.org/10.3892/br.2013.186
  • Pages: 57-62
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Published data on the association between interleukin (IL)‑18 gene polymorphisms (‑137 C/G, ‑607 A/C) and type 1 diabetes (T1D) risk are inconclusive. To obtain a more precise estimation of the association between the IL-18 gene polymorphisms and T1D, a meta‑analysis was performed. A total of 11 studies including 5,945 cases and 6,404 controls were included in the analysis of the association between ‑137 C/G and T1D risk. No significant association between ‑137 C/G and T1D risk was observed in the total population [C vs. G: odds ratio (OR)=1.02, 95% confidence interval (CI)=0.87‑1.20; CC + CG vs. GG: OR=1.05, 95% CI=0.87‑1.25; CC vs. CG + GG: OR=0.96, 95% CI=0.68‑1.36]. No significant association was identified in the stratified analysis for all the genetic models in the European population. Concerning ‑607 A/C, 10 studies involving 3,048 patients and 3,377 controls were included in this meta‑analysis. When all the studies were pooled, the results showed no evidence for a significant association between IL‑18 ‑607 A/C polymorphism and T1D risk (A vs. C: OR=0.93, 95% CI=0.81‑1.06; AA + AC vs. CC: OR=0.99, 95% CI=0.89‑1.10; AA vs. AC + CC: OR=0.81, 95% CI=0.60‑1.09). In addition, similar results were obtained in the subgroup analysis based on ethnicity. In summary, the present meta‑analysis suggests a lack of association between the two polymorphisms (‑137 C/G, ‑607 A/C) in the IL‑18 gene and T1D. Due to the limitation of the number of the studies, the conclusions drawn should be considered with caution. Larger scale primary studies are required to evaluate the association between IL‑18 gene polymorphisms and T1D.
View Figures
View References

Related Articles

Journal Cover

January-February 2014
Volume 2 Issue 1

Print ISSN: 2049-9434
Online ISSN:2049-9442

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.3
  • Ranked
    (total number of cites)
  • CiteScore: 3.7
  • CiteScore Rank: Q2: #23/79 Pharmacology, Toxicology and Pharmaceutics
  • Source Normalized Impact per Paper (SNIP): 0.742
  • SCImago Journal Rank (SJR): 0.488
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Li J, Wu S, Wang MR, Wang TT, Li BK and Zhu JM: Association of the interleukin‑18 ‑137 C/G, ‑607 A/C polymorphisms with type 1 diabetes: A meta‑analysis. Biomed Rep 2: 57-62, 2014
APA
Li, J., Wu, S., Wang, M., Wang, T., Li, B., & Zhu, J. (2014). Association of the interleukin‑18 ‑137 C/G, ‑607 A/C polymorphisms with type 1 diabetes: A meta‑analysis. Biomedical Reports, 2, 57-62. https://doi.org/10.3892/br.2013.186
MLA
Li, J., Wu, S., Wang, M., Wang, T., Li, B., Zhu, J."Association of the interleukin‑18 ‑137 C/G, ‑607 A/C polymorphisms with type 1 diabetes: A meta‑analysis". Biomedical Reports 2.1 (2014): 57-62.
Chicago
Li, J., Wu, S., Wang, M., Wang, T., Li, B., Zhu, J."Association of the interleukin‑18 ‑137 C/G, ‑607 A/C polymorphisms with type 1 diabetes: A meta‑analysis". Biomedical Reports 2, no. 1 (2014): 57-62. https://doi.org/10.3892/br.2013.186